Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit Smoking
This study has been terminated.
( Study terminated due to a technical issue (randomization error). )
Study NCT01296698 Information provided by Johnson & Johnson Consumer and Personal Products Worldwide
First Received on February 14, 2011. Last Updated on March 29, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tobacco Dependence
Additional conditions recognized in this trial
Tobacco Use Disorder
More general conditions related to this trial
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
Placebo
Nicotine
Additional drug interventions recognized in this trial
Nicotine polacrilex
More general drug interventions related to this trial
Autonomic Agents
Central Nervous System Agents
Central Nervous System Stimulants
Cholinergic Agents
Cholinergic Agonists
Ganglionic Stimulants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Nicotinic Agonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
McNeil AB
GlaxoSmithKline
Back to top of Main Content